annamycin has been researched along with verapamil in 2 studies
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
*Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent. [MeSH]
Studies (annamycin) | Trials (annamycin) | Recent Studies (post-2010) (annamycin) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
29 | 3 | 1 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ling, YH; Perez-Soler, R; Priebe, W; Zou, Y | 1 |
Andreeff, M; Consoli, U; Griffin, M; Ling, YH; Mahadevia, R; Perez-Soler, R; Priebe, W; Zhao, S | 1 |
2 other study(ies) available for annamycin and verapamil
Article | Year |
---|---|
Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells.
Topics: Antibiotics, Antineoplastic; Biological Transport; Cell Membrane; Cyclosporine; DNA Replication; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Humans; KB Cells; Microscopy, Fluorescence; Monensin; Nuclear Matrix; Subcellular Fractions; Verapamil | 1995 |
The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Idarubicin; Molecular Structure; Neoplasm Proteins; Structure-Activity Relationship; Verapamil | 1996 |